GF Fund Management
RVMD icon

GF Fund Management’s Revolution Medicines RVMD Stock Holding History

GF Fund Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$867K Buy
4,222
+27
+0.6% +$5.35K 0.01% 190
2026
Q2 		$786K Sell
4,195
-146
-3% -$21.3K 0.01% 195
2026
Q1 		$422K Buy
4,341
+543
+14% +$54.8K 0.01% 231
2025
Q4 		$303K Sell
3,798
-224
-6% -$14.7K 0.01% 254
2025
Q3 		$188K Sell
4,022
-285
-7% -$11.2K ﹤0.01% 297
2025
Q2 		$158K Hold
4,307
– – ﹤0.01% 339
2025
Q1 		$152K Buy
4,307
+775
+22% +$31.5K ﹤0.01% 337
2024
Q4 		$154K Buy
+3,532
New +$178K ﹤0.01% 304

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Mass General Brigham
Mass General Brigham Somerville, Massachusetts $456M AUM 27.51% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

GF Fund Management's RVMD Position: Q3 2026 in Review

GF Fund Management increased its Revolution Medicines (RVMD) stake by 0.64% in Q3 2026, buying an estimated $5.35K and bringing the position to 4,222 shares worth $867K. The position accounts for 0.01% of the portfolio, ranked #190.

GF Fund Management first reported a position in RVMD in Q4 2024 and has held it in 8 quarters since. 284 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • GF Fund Management held 4,222 shares of Revolution Medicines worth $867K as of Q3 2026.
  • GF Fund Management bought 27 Revolution Medicines shares in Q3 2026, an estimated $5.35K.
  • Revolution Medicines made up 0.01% of GF Fund Management's portfolio in Q3 2026, its #190 holding.
  • GF Fund Management first reported a position in Revolution Medicines in Q4 2024 and has held it in 8 quarters since.
  • 284 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.